Ruffer LLP Grifols Sa Transaction History

Ruffer LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$5.47 - $11.38 $1.24 Million - $2.58 Million	-226,315 Reduced 21.03%	850,000 $5.68 Million
Q4 2023 Feb 12, 2024	SELL	$7.71 - $11.56 $858,392 - $1.29 Million	-111,335 Reduced 9.37%	1,076,315 $12.4 Million
Q3 2023 Nov 13, 2023	SELL	$8.91 - $10.91 $40,986 - $50,186	-4,600 Reduced 0.39%	1,187,650 $10.9 Million
Q2 2023 Aug 10, 2023	BUY	$7.14 - $9.29 $8.51 Million - $11.1 Million	1,192,250 New	1,192,250 $10.9 Million

147

151M

2.38M

662K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.57B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Ruffer LLP, based on Form 13F filings with the SEC.

Stay updated on Ruffer LLP with notifications on news.